 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/15/2021 |
$1.97 |
$1.97 |
$1.75 |
$1.84 |
363.80K | | 01/19/2021 |
$1.84 |
$1.93 |
$1.76 |
$1.88 |
273.10K | | 01/20/2021 |
$1.95 |
$1.95 |
$1.85 |
$1.90 |
362.90K | | 01/21/2021 |
$1.98 |
$1.98 |
$1.88 |
$1.90 |
311.00K | | 01/22/2021 |
$1.90 |
$1.95 |
$1.87 |
$1.90 |
141.20K |
|
|
| AgeX Therapeutics is a biotechnology company focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows it to utilize telomerase-expressing regenerative pluripotent stem cells (PSCs) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s product candidates in the discovery stage include two cell-based therapies derived from telomerase-positive PSCs and one product candidate derived from its proprietary induced Tissue Regeneration (iTR™) technology. | |
|
AgeX Therapeutics (AGE) has the following price history information. Looking back at AGE historical stock prices for the last five trading days, on January 15, 2021, AGE opened at $1.97, traded as high as $1.97 and as low as $1.75, and closed at $1.84. Trading volume was a total of 363.80K shares. On January 19, 2021, AGE opened at $1.84, traded as high as $1.93 and as low as $1.76, and closed at $1.88. Trading volume was a total of 273.10K shares. On January 20, 2021, AGE opened at $1.95, traded as high as $1.95 and as low as $1.85, and closed at $1.90. Trading volume was a total of 362.90K shares. On January 21, 2021, AGE opened at $1.98, traded as high as $1.98 and as low as $1.88, and closed at $1.90. Trading volume was a total of 311.00K shares. On January 22, 2021, AGE opened at $1.90, traded as high as $1.95 and as low as $1.87, and closed at $1.90. Trading volume was a total of 141.20K shares.
AGE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AgeX Therapeutics shares, starting with a $10,000 purchase of AGE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/29/2018 |
|
| End date: |
01/22/2021 |
|
| Start price/share: |
$2.71 |
|
| End price/share: |
$1.90 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-29.89% |
|
| Average Annual Total Return: |
-15.22% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$7,011.03 |
|
| Years: |
2.15 |
|
|
|
| Date |
Close |
| 01/15/2021 | $1.84 | | 01/19/2021 | $1.88 | | 01/20/2021 | $1.90 | | 01/21/2021 | $1.90 | | 01/22/2021 | $1.90 |
|
|
